YOLFTbeta
Hims Hers Health Inc

Hims Hers Health Inc

HIMS · NYSE · Healthcare / Drug Manufacturers - Specialty & Generic

19.73USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close19.73
Open19.68
Day Range19.18 – 20.16
52-Week Range13.74 – 41.28
Volume9.93M
Market Cap6.07B
P/E (TTM)0.00
Forward P/E67.57
EPS-0.64
Dividend Yield0.00%
Beta2.50
50-Day Avg28.43
200-Day Avg26.91

About

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Andrew Dudum
  • Employees2.44K
  • Headquarters2269 Chestnut Street, San Francisco, CA, United States, 94123, USA
  • Websitehttps://www.hims.com

Leadership

  • Mr. Andrew DudumCo-Founder, Chairman & CEO · b. 1988
  • Mr. Oluyemi OkupeChief Financial Officer · b. 1986
  • Mr. Mike ChiChief Operating Officer · b. 1980
  • Mr. Mohamed ElShenawyChief Technology Officer · b. 1975
  • Ms. Soleil Teubner Boughton J.D.Chief Legal Officer & Corporate Secretary · b. 1978
  • Dr. Patrick Carroll M.D.Global Chief Medical Officer · b. 1958
  • Ms. Deborah M. Autor J.D.Chief Policy Officer & Director · b. 1967
  • Mr. Jonathan M. FranklinChief Accounting Officer & Principal Accounting Officer · b. 1983
  • Mr. William James NewbySenior Director of Investor Relations
  • Ms. Kathryn H. Beiser B.A., M.S.Chief Communications Officer

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue26.68M82.56M148.76M271.88M526.92M872.00M1.48B2.35B
Growth (%)-+209.45%+80.18%+82.77%+93.81%+65.49%+69.33%+59.00%
Cost of Revenue18.88M37.95M39.31M67.38M118.19M157.05M303.38M614.26M
Gross Profit7.80M44.60M109.45M204.49M408.72M714.95M1.17B1.73B
Gross Margin29.25%54.03%73.58%75.22%77.57%81.99%79.45%73.84%
Operating Expense83.57M119.02M124.59M319.54M477.42M744.40M1.11B1.63B
Operating Income-75.77M-74.41M-15.14M-115.04M-68.70M-29.45M61.90M105.61M
Operating Margin-284.00%-90.14%-10.18%-42.31%-13.04%-3.38%4.19%4.50%
EBITDA--71.34M-14.09M-106.72M-58.23M-12.06M88.80M178.43M
EBITDA Margin--86.42%-9.47%-39.25%-11.05%-1.38%6.01%7.60%
Net Income-75.24M-72.06M-18.11M-107.66M-65.68M-23.55M126.04M128.37M
Net Income Margin-282.03%-87.29%-12.18%-39.60%-12.46%-2.70%8.54%5.47%
R&D--11.24M22.38M29.24M48.23M78.82M149.30M
R&D as % of Total Revenue--7.55%8.23%5.55%5.53%5.34%6.36%
Interest Expense0369.00K10.00K3.80M2.99M---
Interest Expense % of Total Revenue0.00%0.45%0.01%1.40%0.57%---

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets47.52M72.07M118.70M420.58M366.34M441.19M707.54M2.15B
Total Liabilities24.73M207.36M265.57M85.97M54.60M97.16M230.82M1.61B
Total Equity22.79M-135.29M-146.87M334.62M311.74M344.03M476.72M540.93M
Cash41.50M22.65M27.34M71.78M46.77M96.66M220.58M228.62M
Total Debt8.40M1.51M-5.48M5.31M9.95M11.35M1.12B
Net Debt-33.10M-21.13M-27.34M-66.30M-41.47M-86.72M-209.24M891.97M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-57.32M-74.87M-2.48M-34.41M-26.53M73.48M251.08M300.01M
Investing Cash Flow-8.00K-39.30M-39.70M-156.27M34.70M-12.11M-19.05M-1.02B
Financing Cash Flow78.15M95.32M47.74M235.04M-33.13M-11.47M-107.84M729.62M
Capital Expenditure8.00K1.79M4.23M5.01M7.25M26.49M52.75M226.04M
Free Cash Flow-57.33M-76.65M-6.71M-39.42M-33.78M46.99M198.33M73.96M
Dividends Paid--1.74M-----
FCF to OCF100.01%102.39%270.75%114.55%127.32%63.95%78.99%24.65%
Dividend Paid to FCF---25.96%-----

Earnings

Report DateMar 31, 2019Jun 30, 2019Aug 29, 2019Nov 12, 2019Mar 27, 2020May 14, 2020Aug 13, 2020Dec 2, 2020Mar 18, 2021May 17, 2021Aug 11, 2021Nov 10, 2021Feb 22, 2022May 9, 2022Aug 8, 2022Nov 7, 2022Feb 27, 2023May 8, 2023Aug 7, 2023Nov 6, 2023Feb 26, 2024May 6, 2024Aug 5, 2024Nov 4, 2024Feb 24, 2025May 5, 2025Aug 4, 2025Nov 3, 2025Feb 23, 2026May 11, 2026Aug 10, 2026Nov 2, 2026Nov 9, 2026
EPS Estimate0.000.000.00------0.16-0.07-0.06-0.06-0.07-0.06-0.06-0.06-0.070.020.030.05-0.020.080.130.150.220.230.230.230.190.13-0.070.070.07
EPS Actual-0.27-0.27-0.240.020.030.05-0.07-0.06-0.07-0.28-0.09-0.10-0.15-0.08-0.10-0.09-0.050.030.050.060.010.100.160.430.110.280.290.280.22-0.19-0.10--
Surprise--------56.25%-300.00%-50.00%-66.67%-114.29%-33.33%-66.67%-50.00%28.57%50.00%66.67%20.00%150.00%25.00%23.08%186.67%-49.43%21.74%26.09%21.74%15.79%-246.15%-42.86%--
Timing--------After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hours

Key Statistics & Ratios

Market Cap6.07B
Enterprise Value6.77B
Trailing P/E0.00
Forward P/E67.57
PEG Ratio2.37
Price / Sales2.35
Price / Book18.72
EPS-0.64
Book Value1.39
Revenue (TTM)2.58B
Gross Profit (TTM)1.79B
EBITDA-10.18M
Profit Margin-5.51%
Operating Margin-12.75%
Return on Equity-32.03%
Return on Assets-2.21%
Shares Outstanding224.94M
Shares Float213.75M
Beta2.50
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 15 analystsTarget 31.15
  • Strong Buy
    1
  • Buy
    2
  • Hold
    12

Ownership Breakdown

Institutions
71.41%
Insiders
4.94%
Retail / Other
23.65%

Top Institutional Holders

  • BlackRock Inc
    28.70M12.30%
  • Vanguard Portfolio Management, LLC
    10.56M4.53%
  • Vanguard Capital Management, LLC
    9.54M4.09%
  • State Street Corp
    8.15M3.49%
  • Morgan Stanley - Brokerage Accounts
    7.15M3.07%
  • Divisadero Street Capital Management, LP
    6.01M2.58%
  • Geode Capital Management, LLC
    5.68M2.44%
  • The Goldman Sachs Group Inc
    5.17M2.22%
  • JPMorgan Chase & Co
    4.77M2.04%
  • FMR Inc
    4.32M1.85%
  • Marshall Wace Asset Management Ltd
    4.22M1.81%
  • UBS Group AG
    2.66M1.14%
  • Northern Trust Corp
    2.59M1.11%
  • Charles Schwab Investment Management Inc
    2.45M1.05%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    7.60M3.26%
  • Vanguard MStar Total Stk Mkt Idx Invest
    6.75M2.89%
  • iShares Russell 2000 ETF
    5.48M2.35%
  • Vanguard Small Cap Index
    4.81M2.06%
  • Vanguard MStar Small Cap Growth Indx Inv
    2.68M1.15%
  • Fidelity Small Cap Index
    2.37M1.01%